Stanford University: Prostatic Neoplasms trials
The registry lists 26 Prostatic Neoplasms studies with Stanford University as lead sponsor. 0 are open to participants now and 6 have results posted.
Phase 1 5Phase 2 9No phase 13(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound ImagingCompletedNCT04981223Not applicableResults posted
- 68Ga-PSMA PET/CT or PET/MRI in Evaluating Patients With Recurrent Prostate CancerCompletedNCT02488070Phase 1/2Results posted
- 68Ga-DOTA-Bombesin PET/MRI in Imaging Patients With Prostate CancerCompletedNCT02440308Phase 2Results posted
- Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapyTerminatedNCT01450683Phase 2Results posted
- Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate CancerTerminatedNCT00477087Phase 2Results posted
- Fulvestrant in Hormone Refractory Prostate CancerCompletedNCT00476645Phase 2Results posted
- Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation TherapyWithdrawnNCT05415696Not applicable
- Pilot Study for Black Men With Prostate Cancer: Optimization Of Mental and Heart Health, the BOOM-Heart StudyCompletedNCT05099679Not applicable
- 18F-DCFPyL PET/MRI in Regional Nodal&Distant Metastases Detection in Intermediate &HR Prostate CancerApproved for marketingNCT04809584
- Tolerability/Palatability of TalityTM Synthetic Meal Replacement in Prostate CancerCompletedNCT04389918Not applicable
- Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on AbirateroneWithdrawnNCT04296578Phase 1
- Assessment of 3D Transperineal Ultrasound Imaging w/ Matrix Array Transducers in Prostate RadiotherapyTerminatedNCT02432820
- NaF/FDG PET/MRI in Measuring Response to Radium Ra 223 Dichloride in Patients With Metastatic Hormone-Resistant Prostate CancerTerminatedNCT02429804Phase 1
- Transrectal Photoacoustic Imaging of the ProstateTerminatedNCT02365883
- High-Dose Brachytherapy in Treating Patients With Prostate CancerCompletedNCT02346253Not applicable
- Sodium Selenite and Radiation Therapy in Treating Patients With Metastatic CancerCompletedNCT02184533Phase 1
- Photoacoustic Imaging (PAI) of the Prostate: A Clinical Feasibility StudyCompletedNCT01551576
- Real-Time MV/kV Image Guided Radiation TherapyWithdrawnNCT01260909
- Cancer: Thriving and Surviving Online Workshop and Study for Cancer SurvivorsCompletedNCT00962494Phase 2
- Hypofractionated Radiotherapy for Localized Prostate Cancer (With CyberKnife or With IMRT)CompletedNCT00855647Phase 2
- Calcitriol or Placebo in Men for Prostate Cancer Active SurveillanceWithdrawnNCT00482157Not applicable
- A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate CancerTerminatedNCT00383487Phase 2
- Quality of Life Following Radical ProstatectomyCompletedNCT00373308
- Adjuvant Taxotere in Patients With High Risk Prostate Cancer Post Prostatectomy and RadiationCompletedNCT00186420Phase 2
- Microarray Analysis of Gene Expression in Prostate TissuesCompletedNCT00186368
- A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate CancerCompletedNCT00186108Phase 1